Differential effect on different immune subsets of neoadjuvant chemotherapy in patients with TNBC

BACKGROUND: Triple-negative breast cancer (TNBC) is the most aggressive form of breast cancer (BC). Due to the absence of targets such as HER2 or hormone receptors, early TNBC is treated with surgery and chemotherapy. Since TNBC is also considered the most immunogenic type of BC with tumor infiltrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Massa, Chiara, Karn, Thomas, Denkert, Carsten, Schneeweiss, Andreas, Hanusch, Claus, Blohmer, Jens-Uwe, Zahm, Dirk-Michael, Jackisch, Christian, van Mackelenbergh, Marion, Thomalla, Jörg, Marme, Frederik, Huober, Jens, Müller, Volkmar, Schem, Christian, Mueller, Anja, Stickeler, Elmar, Biehl, Katharina, Fasching, Peter A, Untch, Michael, Loibl, Sibylle, Weber, Karsten, Seliger, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670944/
https://www.ncbi.nlm.nih.gov/pubmed/33199511
http://dx.doi.org/10.1136/jitc-2020-001261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670944/
https://www.ncbi.nlm.nih.gov/pubmed/33199511
http://dx.doi.org/10.1136/jitc-2020-001261

Ejemplares similares